Dr Roebuck’s, an Australian skin care brand launched in 2016, has completed a financing round with Unilever Ventures.

The capital raised through this round has not been disclosed.

Recently, the brand expanded its presence to 20 countries. Its products are sold at over 2,000 doors and online through strategic partnerships with Sephora, Shopper’s Drug Mart, Cult Beauty and SpaceNK.

In April, the brand initiated its launch into Sephora Europe and Southeast Asia and now plans to boost its direct retail operations across the world.

The capital raised will be used to speed up its market growth, enhance infrastructure and invest in product innovation and R&D.

Unilever Ventures director Rachel Harris said: “Dr Roebuck’s appealed to us because it is a brand that really lives and breathes clean beauty and its Australian lifestyle roots.

“We look forward to working with Kim, Zoe and Natalie to help further drive Dr Roebuck’s international growth plans.”

The brand was set up by sisters Zoe and Kim Roebuck to honour their parents, who, as physicians, created a clean formula that helped in the treatment of eczema and dry, sensitive skin.

Dr Roebuck’s products made its entry into the US in 2018. The brand’s products are claimed to be cruelty-free, suitable for all skin types, and free of parabens, sulfates, gluten, fillers, synthetic fragrances, harmful chemicals and dyes.

Unilever Ventures is the venture capital and private equity arm of Unilever. It invests in early stage and promising companies.